C: Use with warning if Rewards outweigh pitfalls. Animal reports clearly show risk and human scientific tests not accessible or neither animal nor human scientific tests done.pentobarbital will lower the extent or influence of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is actually a delicate CYP